Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia
Clinical trial NCT03154385 · COMPLETED
Trial details
- NCT number
- NCT03154385
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2019-11-13
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.